الطموح
11-10-2005, Tue 2:28 AM
نبذه عن الشركة
Gilead Sciences, Inc. discovers, develops and commercializes therapeutics to advance the care of patients with life-threatening diseases. For the 6 months ended 6/30/05, revenues rose 47% to $925.7M. Net income rose 56% to $353.1M. Revenues reflect increased sales volume within HIV product franchise. Higher income also reflects lower SG&A expenses as a percentage of sales and an increase in interest and other income
الاشارة شمعة الديلى غالبا مايصحبها ارتفاعات
تحديد نقطة الدخول على ضوء الافتتاح فى الغد باذن الله
Gilead Sciences, Inc. discovers, develops and commercializes therapeutics to advance the care of patients with life-threatening diseases. For the 6 months ended 6/30/05, revenues rose 47% to $925.7M. Net income rose 56% to $353.1M. Revenues reflect increased sales volume within HIV product franchise. Higher income also reflects lower SG&A expenses as a percentage of sales and an increase in interest and other income
الاشارة شمعة الديلى غالبا مايصحبها ارتفاعات
تحديد نقطة الدخول على ضوء الافتتاح فى الغد باذن الله